Science Behind Targeted Drug for Pediatric Brain Cancer Has Dana-Farber Roots 

Dana-Farber researcher Charles Stiles, PhD, remembers the call. It was 2008 and a colleague phoned from a conference to deliver the news. Two separate research teams had discovered a genetic driver for the most common of childhood brain tumors called pediatric low-grade glioma. The problem of finding a genetic target to improve treatment for this … Read more

Pediatric Leukemia Patient Follows in His Father’s Footsteps 

Jake Maguire was just three days away from his sixth birthday when he was diagnosed with acute lymphoblastic leukemia (ALL). Encouraged by his father, a gym teacher, the young Maguire was already in love with sports, especially baseball. Now 23 and over a decade out of treatment, that love is still strong, and Maguire is … Read more

Teen Bounces Back from Solid Tumor Sarcoma with Care Team’s Help 

She may be an accomplished competitive skier, but Maggie Gove, 15, is just as adept at getting up and over mountains as she is racing down them.  Gove is a three-time cancer survivor who has managed to keep up on the slopes and with her studies despite long periods sidelined by surgery, chemotherapy, and radiation … Read more

Study Reveals Inherited Risk Genes for Ewing Sarcoma

A study led by Dana-Farber researchers has revealed that inherited variations in certain DNA damage repair genes may increase an individual’s susceptibility to Ewing sarcoma, an aggressive cancer that tends to strike teenagers and young adults. Ewing sarcoma is rare, with only about one in a million cases diagnosed annually in the United States, and … Read more

Study Provides First In-Depth Look at Major Mix-Ups in the Genomic Terrain of Pediatric High-Grade Glioma

Two major obstacles once stood in the way of exploring the basic biology of diffuse midline glioma in children. And one of them was the brain itself. The cancer, a subtype of high-grade glioma, forms in some of the most critical parts of the brain, in regions that control such basic functions as breathing, swallowing, … Read more

Advances in Myeloma, Breast Cancer, and Clinical Trials Equity: A Dana-Farber Research Update

Results of several phase 3 trials and dozens of other studies led by Dana-Farber researchers were presented online and in person June 3-7 at the 2022 Annual Meeting of the American Society of Clinical Oncology (ASCO), the world’s largest clinical cancer research meeting. Some of the research reports presented by Dana-Farber investigators include: Improved progression-free … Read more

Addressing the Impact of Poverty on Childhood Cancer

Approximately one in three children in the United States lives in a low-income home. For childhood cancer patients, living in a low-income home can have a significant impact: Poverty and associated factors are linked to poorer outcomes, even at large academic medical centers like Dana-Farber, according to research by Kira Bona, MD, MPH, a pediatric … Read more

Researchers Identify Promising Drug Target in Pediatric Neuroblastoma

Investigators had culled the list of suspects down to two. But which one was the guilty party, or were both? The pair worked together so seamlessly, it was difficult to tell where one’s role began and the other’s ended. In some respects, they even looked alike. Dana-Farber scientists have now teased apart the relationship between … Read more

Pediatric Leukemia Patient Takes LEAP to Remission on Precision Medicine Trial

First Cinthia Roman Manrique learned she had acute lymphoblastic leukemia (ALL). Then the 8-year-old Peru native was uprooted from her school, family, and friends when she flew with her mother in early 2017 to the United States — where chances of a cure for her high-risk cancer were better.  In the U.S., Cinthia’s challenges continued … Read more

A Decade Later, Pediatric Cancer Survivor Shares His Experience

Brian Regan knows how overwhelming it can be to hear the words “you have cancer” as a teenager. That is why, nearly a decade after his own diagnosis, he feels compelled to help young patients and families currently grappling with the physical and emotional challenges of treatment. Regan, 27, is a member of the Pediatric … Read more

Pediatric Patient with Leukemia in Remission after Treatment and Transplant

Rosemary Iwakura, 17, was experiencing strange symptoms before her acute lymphoblastic leukemia diagnosis (ALL) almost two years ago. She was unable to focus on her schoolwork or activities and fainted on several occasions at school and at home. “I thought; ‘People faint for many reasons,’” she recalls. “We weren’t sure if we were supposed to … Read more

Pediatric Patient with Rare Leukemia in Remission after Novel Treatment

Nytasha Jette was panicked when her two-month-old son, Elyahs Jones, was found to have an extraordinarily high white blood cell count — over 300,000 — during a regular check-up. The family physician noted that Jones had very pale hands and was worried that the child wasn’t getting proper blood flow. Jette rushed Jones to Dana-Farber/Boston … Read more

Surviving Stem Cell Transplant: New Hope When the Donor Isn’t a Full Match

To see Tara Daniels today, with a corporate job in marketing and about to close on a house, you’d never know what she’s been through, how thrilled she is to be alive. This month marks five years since she received a high-risk bone marrow transplant for a life-threatening blood cancer. Tara woke up feeling sick … Read more

Researchers Solve Mystery of Retinoic Acid’s Potency Against High-Risk Neuroblastoma

For decades, retinoic acid has been a key part of the arsenal against the childhood cancer neuroblastoma. For just as long, scientists have wondered exactly how it works. The answer, Dana-Farber researchers have found, is by reprogramming the activity of two crucial pairs of genes with such precision that the drug almost seems to have … Read more